INS and Hyperglycemia: In particular, the WAT expansion in skeletal muscles and the liver increases the level of diacylglycerol (DAG), which activates the epsilon form of protein kinase C (PKCε), leading to decreased glucose uptake in muscles and disrupts insulin-induced activation of glycogen synthesis and suppression of glucose production in the liver, fueling hyperglycemia (39).